ARTICLE | Top Story
Amylin submits Symlin NDA
December 7, 2000 8:00 AM UTC
AMLN submitted an NDA for Symlin, its synthetic pramlintide analog of the hormone amylin, as an adjunctive treatment for diabetic patients taking insulin. The NDA comes after completion of six Phase I...